Australia's Imricor Medical Systems rises after annual loss narrows
27/02/2025 04:15
** Shares of Imricor Medical Systems IMR.AX rise 4.5% to A$1.525 ** Stock rose as much as 7.2% to A$1.565 earlier in the day, its largest intraday pct gain since February 14 ** The medical device developer narrows FY24 adjusted net loss to $15.6 million vs $16.7 million last year ** Also logs revenue $959,424 for fiscal 2024, up from $615,568 last year ** Says revenue growth driven by capital sales and new site activations ** More than 258,000 shares change hands vs 30-day avg volume of 236,000 shares ** Stock up 13.2% YTD, including current session's moves (Reporting by Nikita Maria Jino in Bengaluru) ((Nikita.Jino@thomsonreuters.com;))
Recent news on Imricor Medical Systems
See all newsBrief: Imricor Medical Systems Says FDA Completes Review Of Imricor's Third PMA Module
Brief: Imricor Medical Systems Says FDA Accepts Imricor Pma Manufacturing Module
Brief: Imricor Medical Systems Says Anticipated FDA Clearances Of Additional Capital Equipment Expected To Broaden Product Offering Available To U.S. Customers
Imricor Medical Systems hits 3-month high on securing first US hospital customer
Brief: Imricor Medical Systems, Receives FDA 510(K) Clearance For Northstar Pediatric Label Expansion